Comerica Bank’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-44,440
| Closed | -$8.11M | – | 2376 |
|
|
2021
Q2 | $8.11M | Sell |
44,440
-1,245
| -3% | -$214K | 0.05% | 443 |
|
|
2021
Q1 | $7.63M | Sell |
45,685
-14,269
| -24% | -$2.21M | 0.05% | 488 |
|
|
2020
Q4 | $9.58M | Sell |
59,954
-2,047
| -3% | -$263K | 0.06% | 350 |
|
|
2020
Q3 | $7.54M | Buy |
62,001
+36
| +0.1% | +$3.88K | 0.05% | 388 |
|
|
2020
Q2 | $6.56M | Buy |
61,965
+3,992
| +7% | +$424K | 0.05% | 399 |
|
|
2020
Q1 | $6.27M | Buy |
57,973
+5,407
| +10% | +$531K | 0.06% | 339 |
|
|
2019
Q4 | $5.27M | Buy |
52,566
+3,150
| +6% | +$337K | 0.04% | 503 |
|
|
2019
Q3 | $5.24M | Sell |
49,416
-3,034
| -6% | -$342K | 0.04% | 484 |
|
|
2019
Q2 | $6.47M | Buy |
52,450
+1,513
| +3% | +$195K | 0.05% | 412 |
|
|
2019
Q1 | $7.2M | Buy |
50,937
+2,819
| +6% | +$351K | 0.06% | 355 |
|
|
2018
Q4 | $5.75M | Buy |
48,118
+768
| +2% | +$90.8K | 0.05% | 429 |
|
|
2018
Q3 | $5.82M | Sell |
47,350
-10,511
| -18% | -$1.32M | 0.05% | 449 |
|
|
2018
Q2 | $7.89M | Buy |
57,861
+1,014
| +2% | +$119K | 0.06% | 383 |
|
|
2018
Q1 | $6.35M | Sell |
56,847
-220
| -0.4% | -$26.3K | 0.05% | 467 |
|
|
2017
Q4 | $7.13M | Sell |
57,067
-2,157
| -4% | -$263K | 0.05% | 448 |
|
|
2017
Q3 | $7.57M | Buy |
59,224
+503
| +0.9% | +$68.3K | 0.05% | 383 |
|
|
2017
Q2 | $7.68M | Sell |
58,721
-10,696
| -15% | -$1.24M | 0.06% | 364 |
|
|
2017
Q1 | $8.81M | Sell |
69,417
-1,120
| -2% | -$144K | 0.07% | 311 |
|
|
2016
Q4 | $9.66M | Sell |
70,537
-2,864
| -4% | -$350K | 0.08% | 257 |
|
|
2016
Q3 | $9.02M | Buy |
73,401
+5,768
| +9% | +$742K | 0.08% | 260 |
|
|
2016
Q2 | $9.13M | Sell |
67,633
-552
| -0.8% | -$78.3K | 0.08% | 245 |
|
|
2016
Q1 | $10.4M | Sell |
68,185
-1,062
| -2% | -$156K | 0.09% | 201 |
|
|
2015
Q4 | $11.6M | Buy |
69,247
+1,972
| +3% | +$344K | 0.11% | 169 |
|
|
2015
Q3 | $10.5M | Sell |
67,275
-60,811
| -47% | -$11.1M | 0.1% | 190 |
|
|
2015
Q2 | $23.2M | Buy |
128,086
+68,893
| +116% | +$11.9M | 0.1% | 196 |
|
|
2015
Q1 | $10.3M | Sell |
59,193
-56,823
| -49% | -$10.3M | 0.09% | 223 |
|
|
2014
Q4 | $21.5M | Buy |
116,016
+59,348
| +105% | +$11M | 0.09% | 210 |
|
|
2014
Q3 | $9.4M | Sell |
56,668
-4,227
| -7% | -$694K | 0.08% | 224 |
|
|
2014
Q2 | $9.52M | Sell |
60,895
-18,137
| -23% | -$2.86M | 0.08% | 230 |
|
|
2014
Q1 | $12M | Sell |
79,032
-481
| -0.6% | -$76.5K | 0.09% | 214 |
|
|
2013
Q4 | $10.6M | Sell |
79,513
-4,793
| -6% | -$575K | 0.08% | 231 |
|
|
2013
Q3 | $9.79M | Sell |
84,306
-1,733
| -2% | -$190K | 0.07% | 275 |
|
|
2013
Q2 | $7.94M | Buy |
+86,039
| New | +$8.29M | 0.06% | 297 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM